Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test sale cost 6000 AED
Solid Tumor Combo2 MSINRASKRASBRAFH RAS Test sale cost 7200 AED Solid Tumor Combo2 MSINRASKRASBRAFH RAS Test Cost 9,600 د.إ Original price was: 9,600 د.إ.7,200 د.إCurrent price is: 7,200 د.إ.
Microarray 60K AFCVS and Karyotyping and FISH Chromosome 21 Test sale cost 5200 AED Microarray 60K AFCVS and Karyotyping and FISH Chromosome 21 Test Cost 7,000 د.إ Original price was: 7,000 د.إ.5,200 د.إCurrent price is: 5,200 د.إ.
Sale!

Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test Cost

Original price was: 8,000 د.إ.Current price is: 6,000 د.إ.

-25%

The “Lung Cancer Panel 6 EGFR by Sequencing, ALK by IHC, ROS1 by FISH Test” is a comprehensive diagnostic panel offered by DNA Labs UAE, designed to detect specific genetic mutations and alterations in lung cancer patients. This panel includes three critical tests: EGFR mutation analysis by sequencing, ALK rearrangements by Immunohistochemistry (IHC), and ROS1 rearrangements by Fluorescence in situ hybridization (FISH).

1. **EGFR by Sequencing**: This part of the panel identifies mutations in the EGFR gene, which can influence the growth and spread of cancer cells. Sequencing the EGFR gene helps in determining the eligibility of patients for targeted therapy using EGFR inhibitors.

2. **ALK by IHC**: ALK testing by IHC (Immunohistochemistry) is used to detect rearrangements in the ALK gene. These rearrangements can lead to abnormal cell growth and cancer. Identifying ALK rearrangements is crucial for selecting patients who may benefit from ALK inhibitors, a targeted cancer therapy.

3. **ROS1 by FISH**: The ROS1 portion utilizes Fluorescence in situ hybridization (FISH) to identify rearrangements in the ROS1 gene. Similar to ALK, ROS1 rearrangements are actionable targets in lung cancer treatment, with specific inhibitors available for patients with these genetic alterations.

Priced at 6000 AED, this panel is a valuable tool for the personalized management of lung cancer, enabling healthcare providers to tailor treatment strategies based on the genetic profile of a patient’s tumor. Conducted at DNA Labs UAE, a facility known for its cutting-edge technology and expertise in genetic testing, this panel ensures accurate and reliable results, guiding the course of treatment for lung cancer patients towards more effective and targeted therapies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test

Welcome to DNA Labs UAE, a leading genetic lab specializing in diagnostic tests for various conditions. Today, we will be discussing the Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test.

Test Details

The Lung Cancer Panel 6 is a comprehensive diagnostic test used to detect lung cancer in patients. This panel consists of three different tests:

  1. EGFR by Sequencing
  2. ALK by IHC
  3. ROS1 by FISH

The cost of this test is 6000.0 AED and the sample condition required is tumor tissue. The report delivery time is estimated to be 5-7 days.

EGFR by Sequencing

This test is specifically designed to detect mutations in the EGFR gene. EGFR mutations are commonly found in non-small cell lung cancer (NSCLC) and can provide valuable information for treatment decisions. Patients with EGFR mutations may be eligible for targeted therapies such as tyrosine kinase inhibitors.

ALK by IHC

The ALK by IHC test is used to identify the presence of the ALK protein. ALK rearrangements are also frequently observed in NSCLC and can help guide treatment choices. Patients with ALK rearrangements may be suitable for targeted therapies such as ALK inhibitors.

ROS1 by FISH

The ROS1 by FISH test is utilized to detect rearrangements in the ROS1 gene. While ROS1 rearrangements are less common than EGFR and ALK mutations, they still indicate potential treatment options with ROS1 inhibitors.

Overall, the Lung Cancer Panel 6 provides a comprehensive approach to detecting lung cancer and identifying potential treatment options for patients. It is important to note that a doctor’s prescription is required for this test, except for surgery and pregnancy cases or individuals planning to travel abroad.

Conclusion

If you suspect lung cancer or are looking for more information about the Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test, we encourage you to consult with an oncologist. At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services to support personalized treatment plans. Contact us today to learn more.

Test Name Lung Cancer Panel 6 EGFR by SequencingALK by IHC ROS1 by FISH Test
Components Paraffin embedded tissue blocks
Price 6000.0 AED
Sample Condition Tumor tissue
Report Delivery 5-7 days
Method FISH,Sanger Sequencing,IHC
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Lung Cancer Panel 6 EGFR by Sequencing,ALK by IHC, ROS1 by FISH] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Lung Cancer Panel 6 is a diagnostic test that is used to detect lung cancer in patients. This panel includes three different tests: EGFR by sequencing, ALK by IHC, and ROS1 by FISH.

EGFR by sequencing: This test is used to detect mutations in the EGFR gene. EGFR mutations are common in non-small cell lung cancer (NSCLC) and can help guide treatment decisions. Patients with EGFR mutations may be candidates for targeted therapies such as tyrosine kinase inhibitors.

ALK by IHC: This test is used to detect the presence of the ALK protein. ALK rearrangements are also common in NSCLC and can also guide treatment decisions. Patients with ALK rearrangements may be candidates for targeted therapies such as ALK inhibitors.

ROS1 by FISH: This test is used to detect rearrangements in the ROS1 gene. ROS1 rearrangements are less common than EGFR and ALK mutations, but they also indicate a potential for targeted therapy with ROS1 inhibitors.

Overall, the Lung Cancer Panel 6 provides a comprehensive approach to detecting lung cancer and identifying potential treatment options for patients.

SKU: TEST-770 Category:

Related products